Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C]elacridar and [11C]tariquidar PET visualization of P-glycoprotein in humans
2010-020759-30Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tariquidar, sponsored by Medical University of Vienna. Primary endpoint: Brain time-activity curves of [11C]elacridar, [11C]tariquidar and (R)-[11C]verapamil. Started Jul 2010; status: completed.
02
Drugs
tariquidar
Beyond the preview
Go deeper on 2010-020759-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020759-30.